AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AccurECG TM software platform has ...

New research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need ...

defined as 12-month freedom from a documented 30-second episode of Afib/atrial flutter/atrial tachycardia, failure of pulmonary vein isolation (PVI), cardioversion, antiarrhythmic drug use ...

The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...

Additionally, 81% showed no afib recurrence—including no need for taking new anti-arrhythmic medications—and 96.4% of people treated with Farapoint had no recurrence of atrial flutter.

Atrial flutter is similar to atrial fibrillation (AF) in regard to symptoms and thromboembolic risk, including stroke. However, the pathophysiology and management differ. Symptoms of AF reflect ...

The study also included patients with atrial flutter, with one in four cases missed ... the potential of wearable tech for identifying AFib, the researchers – from Oxford University Hospital ...

In the single-arm PULSAR IDE study of 162 people, the novel PFA system demonstrated 78% primary effectiveness, defined as 12-month freedom from a documented 30-second episode of Afib/atrial ...

For medically refractory vasovagal syncope (VVS) and functional bradycardia, the feasibility of off-label catheter cardioneuroablation (CNA) was supported by multicenter U.S. registry data.

Pulsed field ablation dominated discussions and scientific sessions at Heart Rhythm 2025 in San Diego with researchers and manufacturers touting new applications in persistent atrial fibrillation, ...